MYCN and neuroblastoma: With detection of a MYCN amplification in 9 out of 20 neuroblastomas and the detection of 1p36 loss in 8 out of 20 neuroblastomas, results obtained with the NB-HCPS assay were in concordance with the results obtained by the reference laboratory, except for one case (Figure 2A,B, Table S10).